Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
April 29, 2011
Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition
Hadine Joffe, Laura Fagioli Petrillo, Alexia Koukopoulos, et al.
General Hospital Psychiatry
|
June 30, 2018
Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders
Marlene P Freeman, Lina Góez-Mogollón, Kathryn A McInerney, et al.
Journal of Women'S Health (2002)
|
July 22, 2024
The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Alexia Jones, Mercedes J Szpunar, et al.
The Journal of Clinical Psychiatry
|
January 5, 2023
Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Sara A McElheny, Phoebe S Caplin, et al.
Archives of Women'S Mental Health
|
March 12, 2021
Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Marlene P Freeman, Adele C Viguera, Lina Góez-Mogollón, et al.
Archives of Women'S Mental Health
|
April 22, 2021
Correction to: Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Marlene P Freeman, Adele C Viguera, Lina Góez-Mogollón, et al.
Journal of Women'S Health (2002)
|
January 30, 2023
Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications
Lee S Cohen, Taylor R Church, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry
|
October 5, 2021
Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Adele C Viguera, Marlene P Freeman, Lina Góez-Mogollón, et al.
The Journal of Clinical Psychiatry
|
August 5, 2021
Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Adele C Viguera, Marlene P Freeman, Lina Góez-Mogollón, et al.
The American Journal of Psychiatry
|
August 3, 2007
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes
D Jeffrey Newport, Martha R Calamaras, C Lindsay DeVane, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Endocrinology and Metabolism
|
April 29, 2011
Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition
Hadine Joffe, Laura Fagioli Petrillo, Alexia Koukopoulos, et al.
General Hospital Psychiatry
|
June 30, 2018
Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders
Marlene P Freeman, Lina Góez-Mogollón, Kathryn A McInerney, et al.
Journal of Women'S Health (2002)
|
July 22, 2024
The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Alexia Jones, Mercedes J Szpunar, et al.
The Journal of Clinical Psychiatry
|
January 5, 2023
Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications
Adele C Viguera, Sara A McElheny, Phoebe S Caplin, et al.
Archives of Women'S Mental Health
|
March 12, 2021
Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Marlene P Freeman, Adele C Viguera, Lina Góez-Mogollón, et al.
Archives of Women'S Mental Health
|
April 22, 2021
Correction to: Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Marlene P Freeman, Adele C Viguera, Lina Góez-Mogollón, et al.
Journal of Women'S Health (2002)
|
January 30, 2023
Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications
Lee S Cohen, Taylor R Church, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry
|
October 5, 2021
Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Adele C Viguera, Marlene P Freeman, Lina Góez-Mogollón, et al.
The Journal of Clinical Psychiatry
|
August 5, 2021
Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Adele C Viguera, Marlene P Freeman, Lina Góez-Mogollón, et al.
The American Journal of Psychiatry
|
August 3, 2007
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes
D Jeffrey Newport, Martha R Calamaras, C Lindsay DeVane, et al.
Page
of 10